“IDENTIFICATION OF ENDOGENOUS SUPEROXIDE DISMUTASE AS A POTENTIAL INHIBITOR FOR PI3K/AKT SIGNALING IN COLORECTAL CANCER - A MOLECULAR DOCKING STUDY”, Journal of Pharmaceutical Negative Results, pp. 1374–1379, Oct. 2022, doi: 10.47750/pnr.2022.13.S03.214.